NATERA, INC. Interest Expense
NATERA, INC. (NTRA) reported Interest Expense of $4.07 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-02-27
- NATERA, INC. interest expense for the quarter ending 2025-12-31 was $991.00K, a 23.30% decline year-over-year.
- NATERA, INC. interest expense for the quarter ending 2025-09-30 was $1.04M, a 66.74% decline year-over-year.
- NATERA, INC. interest expense for the quarter ending 2025-06-30 was $1.03M, a 67.09% decline year-over-year.
- NATERA, INC. interest expense for the quarter ending 2025-03-31 was $1.00M, a 67.83% decline year-over-year.
- NATERA, INC. interest expense for fiscal 2025 was $4.07M, a 61.92% decline from fiscal 2024.
- NATERA, INC. interest expense for fiscal 2024 was $10.69M, a 15.45% decline from fiscal 2023.
- NATERA, INC. interest expense for fiscal 2023 was $12.64M, a 35.62% increase from fiscal 2022.
- NATERA, INC. interest expense for fiscal 2022 was $9.32M, a 12.21% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $991.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.04M derived: sum of 2 quarters · filed 2026-02-27 | $3.06M derived: sum of 3 quarters · filed 2026-02-27 | $4.07M 10-K · filed 2026-02-27 |
| 2025-09-30 | $1.04M 10-Q · filed 2025-11-07 | $2.07M derived: sum of 2 quarters · filed 2025-11-07 | $3.08M 10-Q · filed 2025-11-07 | $4.37M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | $1.03M 10-Q · filed 2025-08-08 | $2.03M 10-Q · filed 2025-08-08 | $3.33M derived: sum of 3 quarters · filed 2026-02-27 | $6.47M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | $1.00M 10-Q · filed 2025-05-09 | $2.30M derived: sum of 2 quarters · filed 2026-02-27 | $5.44M derived: sum of 3 quarters · filed 2026-02-27 | $8.57M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.43M derived: sum of 2 quarters · filed 2026-02-27 | $7.56M derived: sum of 3 quarters · filed 2026-02-27 | $10.69M 10-K · filed 2026-02-27 |
| 2024-09-30 | $3.14M 10-Q · filed 2025-11-07 | $6.27M derived: sum of 2 quarters · filed 2025-11-07 | $9.39M 10-Q · filed 2025-11-07 | $12.54M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $3.13M 10-Q · filed 2025-08-08 | $6.25M 10-Q · filed 2025-08-08 | $9.40M derived: sum of 3 quarters · filed 2026-02-27 | $12.65M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $3.12M 10-Q · filed 2025-05-09 | $6.27M derived: sum of 2 quarters · filed 2026-02-27 | $9.52M derived: sum of 3 quarters · filed 2026-02-27 | $12.70M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $6.40M derived: sum of 2 quarters · filed 2026-02-27 | $9.58M derived: sum of 3 quarters · filed 2026-02-27 | $12.64M 10-K · filed 2026-02-27 |
| 2023-09-30 | $3.25M 10-Q · filed 2024-11-12 | $6.43M derived: sum of 2 quarters · filed 2024-11-12 | $9.49M 10-Q · filed 2024-11-12 | $12.24M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $3.18M 10-Q · filed 2024-08-09 | $6.24M 10-Q · filed 2024-08-09 | $8.99M derived: sum of 3 quarters · filed 2025-02-28 | $11.32M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $3.06M 10-Q · filed 2024-05-10 | $5.81M derived: sum of 2 quarters · filed 2025-02-28 | $8.14M derived: sum of 3 quarters · filed 2025-02-28 | $10.29M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $5.08M derived: sum of 2 quarters · filed 2025-02-28 | $7.23M derived: sum of 3 quarters · filed 2025-02-28 | $9.32M 10-K · filed 2025-02-28 |
| 2022-09-30 | $2.33M 10-Q · filed 2023-11-09 | $4.48M derived: sum of 2 quarters · filed 2023-11-09 | $6.57M 10-Q · filed 2023-11-09 | $8.65M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $2.15M 10-Q · filed 2023-08-04 | $4.24M 10-Q · filed 2023-08-04 | $6.32M derived: sum of 3 quarters · filed 2024-02-29 | $8.39M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $2.09M 10-Q · filed 2023-05-10 | $4.17M derived: sum of 2 quarters · filed 2024-02-29 | $6.24M derived: sum of 3 quarters · filed 2024-02-29 | $8.32M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $4.16M derived: sum of 2 quarters · filed 2024-02-29 | $6.23M derived: sum of 3 quarters · filed 2024-02-29 | $8.30M 10-K · filed 2024-02-29 |
| 2021-09-30 | $2.08M 10-Q · filed 2022-11-09 | $4.15M derived: sum of 2 quarters · filed 2022-11-09 | $6.23M 10-Q · filed 2022-11-09 | $10.54M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $2.08M 10-Q · filed 2022-08-05 | $4.15M 10-Q · filed 2022-08-05 | $8.46M derived: sum of 3 quarters · filed 2023-03-01 | $12.73M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $2.07M 10-Q · filed 2022-05-06 | $6.38M derived: sum of 2 quarters · filed 2023-03-01 | $10.65M derived: sum of 3 quarters · filed 2023-03-01 | $14.69M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $8.58M derived: sum of 2 quarters · filed 2023-03-01 | $12.62M derived: sum of 3 quarters · filed 2023-03-01 | $15.08M 10-K · filed 2023-03-01 |
| 2020-09-30 | $4.27M 10-Q · filed 2021-11-05 | $8.31M derived: sum of 2 quarters · filed 2021-11-05 | $10.77M 10-Q · filed 2021-11-05 | $13.35M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $4.04M 10-Q · filed 2021-08-06 | $6.50M 10-Q · filed 2021-08-06 | $9.08M derived: sum of 3 quarters · filed 2022-02-25 | $11.75M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $2.46M 10-Q · filed 2021-05-07 | $5.04M derived: sum of 2 quarters · filed 2022-02-25 | $7.71M derived: sum of 3 quarters · filed 2022-02-25 | $10.43M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $5.25M derived: sum of 2 quarters · filed 2022-02-25 | $7.97M derived: sum of 3 quarters · filed 2022-02-25 | $10.69M 10-K · filed 2022-02-25 |
| 2019-09-30 | $2.67M 10-Q · filed 2020-11-06 | $5.39M derived: sum of 2 quarters · filed 2020-11-06 | $8.12M 10-Q · filed 2020-11-06 | $10.86M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $2.72M 10-Q · filed 2020-08-07 | $5.45M 10-Q · filed 2020-08-07 | $8.19M derived: sum of 3 quarters · filed 2021-02-26 | $10.97M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $2.72M 10-Q · filed 2020-05-08 | $5.47M derived: sum of 2 quarters · filed 2021-02-26 | $8.25M derived: sum of 3 quarters · filed 2021-02-26 | $10.81M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $5.53M derived: sum of 2 quarters · filed 2021-02-26 | $8.09M derived: sum of 3 quarters · filed 2021-02-26 | $10.48M 10-K · filed 2021-02-26 |
| 2018-09-30 | $2.78M 10-Q · filed 2019-11-08 | $5.34M derived: sum of 2 quarters · filed 2019-11-08 | $7.73M 10-Q · filed 2019-11-08 | $10.06M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $2.56M 10-Q · filed 2019-08-09 | $4.95M 10-Q · filed 2019-08-09 | $7.28M derived: sum of 3 quarters · filed 2020-03-02 | $8.76M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $2.39M 10-Q · filed 2019-05-10 | $4.72M derived: sum of 2 quarters · filed 2020-03-02 | $6.20M derived: sum of 3 quarters · filed 2020-03-02 | $6.42M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $3.81M derived: sum of 2 quarters · filed 2020-03-02 | $4.03M derived: sum of 3 quarters · filed 2020-03-02 | $4.21M 10-K · filed 2020-03-02 |
| 2017-09-30 | $1.48M 10-Q · filed 2018-11-09 | $1.70M derived: sum of 2 quarters · filed 2018-11-09 | $1.88M 10-Q · filed 2018-11-09 | $2.03M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $218.00K 10-Q · filed 2018-08-09 | $401.00K 10-Q · filed 2018-08-09 | $551.00K derived: sum of 3 quarters · filed 2019-03-15 | $697.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $183.00K 10-Q · filed 2018-05-10 | $333.00K derived: sum of 2 quarters · filed 2019-03-15 | $479.00K derived: sum of 3 quarters · filed 2019-03-15 | $601.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $296.00K derived: sum of 2 quarters · filed 2019-03-15 | $418.00K derived: sum of 3 quarters · filed 2019-03-15 | $533.00K 10-K · filed 2019-03-15 |
| 2016-09-30 | $146.00K 10-Q · filed 2017-11-09 | $268.00K derived: sum of 2 quarters · filed 2017-11-09 | $383.00K 10-Q · filed 2017-11-09 | $497.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $122.00K 10-Q · filed 2017-08-09 | $237.00K 10-Q · filed 2017-08-09 | $351.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.53M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $115.00K 10-Q · filed 2017-05-10 | $229.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.41M derived: sum of 3 quarters · filed 2018-03-15 | $2.61M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.29M derived: sum of 2 quarters · filed 2018-03-15 | $2.49M derived: sum of 3 quarters · filed 2018-03-15 | $3.50M 10-K · filed 2018-03-15 |
| 2015-09-30 | $1.18M 10-Q · filed 2016-11-14 | $2.38M derived: sum of 2 quarters · filed 2016-11-14 | $3.39M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $1.20M 10-Q · filed 2016-08-11 | $2.21M 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $1.01M 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | $4.22M 10-K · filed 2017-03-16 | |||
| 2013-12-31 | $1.87M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |